Jci_page_head_homepage_01 Jci_page_head_homepage_02
Balasubramanian Krishnamurthy, Nadine L. Dudek, Mark D. McKenzie, Anthony W. Purcell, Andrew G. Brooks, Shane Gellert, Peter G. Colman, Leonard C. Harrison, Andrew M. Lew, Helen E. Thomas, Thomas W.H. Kay
Published in Volume 116, Issue 12
J Clin Invest. 2006; 116(12):3258–3265 doi:10.1172/JCI29602
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 4
Expression of IGRP in NOD-IGRP mice.

(A) Expression of transgenic IGRP mRNA in the thymi of NOD-IGRP or nontransgenic control littermates as compared with IGRP mRNA in islets of NOD mice. Total RNA from NOD-IGRP mice and nontransgenic control littermates was reverse transcribed using random primers. Real-time RT-PCR was performed with Assay-on-Demand kits for mouse IGRP and β-actin. (B) Functional IGRP expression in APCs of NOD-IGRP mice. CD8+ T cells from a NOD8.3 mouse were labeled with CFSE and transferred into 6-week-old NOD-IGRP or nontransgenic control littermates (n = 4 per group). Recipients were sacrificed 3 days later, and their PLNs and ILNs were examined for CFSE+ cells. The numbers within the histogram plots indicate percentages of CFSE-low cells.